RECRUITING

Exercise As Maintenance Therapy in Advanced Lung Cancer

Talk to us

Conditions

Lung CancerNon Small Cell Lung CancerMetastatic Lung Cancerexercise

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to examine how a multimodality (having or using a variety of methods to do something) exercise intervention may improve survival, function, and quality of life in participants with advanced lung cancer.

Official Title

Exercise As Maintenance Therapy in Advanced Lung Cancer

Quick Facts

Study Start:2024-10-15
Study Completion:2029-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06513663

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age ≥ 18 years
  2. 2. Known diagnosis of locally advanced (stage III) or metastatic NSCLC
  3. 3. Patient is currently receiving maintenance immunotherapy for at least 1 month and planned for at least 3 additional months of therapy
  4. 1. Patients receiving maintenance therapy refers to patients with stable disease or partial response to therapy, including patients who have had a history of disease progression but are currently stable or responding to a different therapy
  5. 2. Patients previously receiving chemotherapy are eligible as long as at least one month has elapsed since completing chemotherapy. Those currently receiving chemotherapy are not eligible.
  6. 4. Patient is willing and able to participate in a supervised home-based exercise program as determined by the MOVE program
  7. 5. ECOG performance status of 0-2
  1. 1. Already meeting exercise guidelines and participating in at least 150 minutes of moderate or vigorous exercise per IPAQ
  2. 2. Unable to participate in the supervised home-based exercise program as determined by the MOVE program
  3. 3. Medical co-morbidities that preclude patient from participating in supervised exercise, including but not limited to:
  4. * Advanced heart failure
  5. * Advanced respiratory disease requiring home oxygen use
  6. * Uncontrolled psychiatric disorders
  7. * History of fragility fracture

Contacts and Locations

Study Contact

Nada Kassem
CONTACT
317-278-5238
nakassem@iu.edu
Tarah J Ballinger, MD
CONTACT
tarahb@iu.edu

Principal Investigator

Tarah J Ballinger, MD
PRINCIPAL_INVESTIGATOR
Indiana University

Study Locations (Sites)

Indiana University Health Methodist Hospital
Indianapolis, Indiana, 46202
United States
Indiana University Melvin & Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202
United States
Sidney and Lois Eskenazi Hospital
Indianapolis, Indiana, 46202
United States

Collaborators and Investigators

Sponsor: Indiana University

  • Tarah J Ballinger, MD, PRINCIPAL_INVESTIGATOR, Indiana University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-15
Study Completion Date2029-12

Study Record Updates

Study Start Date2024-10-15
Study Completion Date2029-12

Terms related to this study

Keywords Provided by Researchers

  • lung cancer
  • exercise
  • non small cell lung cancer

Additional Relevant MeSH Terms

  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Metastatic Lung Cancer